Worthing rolls out animal-free bioprocessing enzymes

By Gareth Macdonald

- Last updated on GMT

Worthing Biochemical launches animal free enzymes
Worthing Biochemical launches animal free enzymes
Worthing Biochemical has launched a range of animal product-free bioprocessing enzymes citing demand for products with no risk of TSE contamination.

The new enzymes – which include collagenases, nucleases and proteases – are certified “xeno-free” - meaning that they contain no non-human animal products. This minimizes the risk of contamination by prion diseases or mammalian viruses according to Worthing.

Company vice president Jim Zacka said: “The use of animal free enzymes eliminates many of the quality and regulatory issues and concerns associated with enzymes commonly purified from animal sources​.”

He added that: “The demand for safer enzymes and biopharmaceuticals has led Worthington to develop an array of Animal Free (AF) enzymes for biomedical research and related bioprocessing applications​.”

Worthing makes its enzymes at its ISO 9001 Certified facility located in the Lakewood, New Jersey, deriving them from fungal and bacterial sources.

Related news

Related products

show more

Connectivity & Integration in Biomanufacturing

Connectivity & Integration in Biomanufacturing

Wheeler Bio | 17-Nov-2022 | Technical / White Paper

As the Pharma 4.0 initiative sets a new industry paradigm, more biomanufacturing companies are asking how they can design and build facilities that apply...

GMP manufacturing of buffers and liquid blends

GMP manufacturing of buffers and liquid blends

Actylis – The Partner of Choice | 16-Nov-2022 | Technical / White Paper

Actylis manufactures buffers, process solutions, cleaning solutions, Water for Injection (WFI) for further processing, and custom liquid blends in compliance...

Custom manufacturing of protease inhibitor PMSF

Custom manufacturing of protease inhibitor PMSF

Actylis – The Partner of Choice | 09-Nov-2022 | Technical / White Paper

By combining 75+ years of manufacturing and sourcing expertise, Actylis provides a wide portfolio of GMP ingredients to the pharma & biopharma market,...

Scalability, Quality, and Speed with Transposons

Scalability, Quality, and Speed with Transposons

Wheeler Bio | 20-Oct-2022 | Technical / White Paper

To solve for the significant bottlenecks often presented by conventional cell line development processes, this article discusses how Wheeler Bio is leveraging...

Related suppliers

Follow us

Products

View more

Webinars